As artificial intelligence reshapes the pharmaceutical landscape, I am compelled to synthesize the key milestones and reflections from my LinkedIn series, The Promise AI Journey, into this first comprehensive summary. This article distills lessons from building AI roadmaps, navigating Pharma’s unique challenges, and envisioning a future where AI accelerates both innovation and ethical responsibility.
The pharmaceutical industry stands on the brink of an AI revolution, yet a significant gap exists between potential and practical application. Discover why embracing AI fully is crucial for the future of pharmaceuticals.
Strategic storytelling has emerged as a compelling tool for pharma brands to effectively engage and connect with their target audiences. By leveraging the power of storytelling, pharma brands can communicate their messages, build relationships, and establish an emotional connection with customers
Storytelling in healthcare marketing is a tool that allows you to tell a story using sensory language presented in a way that enables listeners to internalise it, understand it and create their own meaning. Your customers do not buy your product or service. They buy the emotion you make them feel.
Most of the decisions people make are not based on logic. The hippocampus, the logical part of the brain, is only 2% of the brain. So, if we want to change people's behavior, their logic is the weakest tool. To change behavior, pharmaceutical brands have to tap into emotions.
The pharmaceutical industry is economically and socially critical. However, it constantly faces multiple challenges that question the sustainability of several companies. Even before the pandemic, launching a new brand was far from straightforward. A successful launch must overcome a series of barriers, including supply chain, intensifying competition, increasing pricing pressure, increasing market entry barriers, and rising expectations among caregivers and patients.
A first-class customer service experience has as goal to ‘delight’ customers by anticipating the unexpressed wishes of their guests. Customer data is used to shape a personalized experience, and an innovation database stores ideas to share across properties
The pandemic put patients at the center of every conversation, catalyzed innovation. Over the last two years, collaboration across life sciences and with stakeholders has been unprecedented, with everyone mobilizing in the interest of patients.
In the pharmaceutical industry, as in many others, the COVID-19 pandemic has suddenly forced companies to operate differently. Ways had to be found to make fast decisions, even though it was sometimes difficult to convene all those in the organization that would usually be part of the process
In technological terms, the future is already here. But in many provider organizations, the plan for working in that future is still on the drawing board. Organizations have the opportunity to fuse talent and technology or to have them “join forces” instead of burdening or competing with one another. To do so they need to intentionally coordinate human and technological resources from the outset.